Skip to main content
. 2020 May 14;26(18):2138–2154. doi: 10.3748/wjg.v26.i18.2138

Figure 1.

Figure 1

Proposal of a treatment algorithm for diabetes mellitus type II in liver transplant recipients. GLP-1 RA: Glucagon-like peptide-1 receptor agonist; SGLT2 inhibitors: Sodium-glucose cotransporter type 2; DPP-4l: Inhibitors of dipeptidyl peptidase 4; NASH: Non-alcoholic steatohepatitis; NAFLD: Non-alcoholic fatty liver disease.